蓝丰生化：股东海南闻勤计划减持公司股份不超过约980万股

Group 1 - The major shareholder, Hainan Wenqin Private Fund Management Partnership, plans to reduce its stake in Lanfeng Biochemical by up to approximately 9.8 million shares, which represents 2.61% of the total share capital [2] - The reduction will occur within three months after the announcement, with a maximum of 1% through centralized bidding and 2% through block trading [2] Group 2 - For the year 2024, Lanfeng Biochemical's revenue composition is projected to be 67.66% from photovoltaic products and 32.34% from pesticides [3]